Oral BG-12 (Dimethyl Fumarate) Significantly Reduced Multiple Sclerosis (MS) Relapses and Disability Progression in Define Phase 3 Clinical Trial --240 mg of BG-12 Administered Either Twice or Three ...
Characteristics and survival of African American (AA) newly diagnosed multiple myeloma (NDMM) patients (Pts): A report from the Connect MM Registry. Real world impact of treatment-induced peripheral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback